In addition, 255 improved the cognitive impairment, increased ChAT and superoxide dismutase activity, and decreased AChE activity and malondialdehyde (MDA) levels in the Aβ i.c.v. AD model. This evidence concerns the gene ACHE and Alzheimer disease.